JP2001504828A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504828A5
JP2001504828A5 JP1998523502A JP52350298A JP2001504828A5 JP 2001504828 A5 JP2001504828 A5 JP 2001504828A5 JP 1998523502 A JP1998523502 A JP 1998523502A JP 52350298 A JP52350298 A JP 52350298A JP 2001504828 A5 JP2001504828 A5 JP 2001504828A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998523502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504828A (ja
Filing date
Publication date
Priority claimed from EP96203234A external-priority patent/EP0842657A1/en
Application filed filed Critical
Priority claimed from PCT/NL1997/000625 external-priority patent/WO1998022093A1/en
Publication of JP2001504828A publication Critical patent/JP2001504828A/ja
Publication of JP2001504828A5 publication Critical patent/JP2001504828A5/ja
Ceased legal-status Critical Current

Links

JP52350298A 1996-11-19 1997-11-17 制御型放出システムの調製方法 Ceased JP2001504828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96203234.8 1996-11-19
EP96203234A EP0842657A1 (en) 1996-11-19 1996-11-19 Microspheres for controlled release and processes to prepare these microspheres
PCT/NL1997/000625 WO1998022093A1 (en) 1996-11-19 1997-11-17 Process for the preparation of a controlled release system

Publications (2)

Publication Number Publication Date
JP2001504828A JP2001504828A (ja) 2001-04-10
JP2001504828A5 true JP2001504828A5 (enExample) 2004-09-02

Family

ID=8224598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52350298A Ceased JP2001504828A (ja) 1996-11-19 1997-11-17 制御型放出システムの調製方法

Country Status (3)

Country Link
US (1) US6303148B1 (enExample)
EP (1) EP0842657A1 (enExample)
JP (1) JP2001504828A (enExample)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
US6153211A (en) * 1997-07-18 2000-11-28 Infimed, Inc. Biodegradable macromers for the controlled release of biologically active substances
ATE364374T1 (de) 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
ATE466603T1 (de) 1998-04-27 2010-05-15 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
EP1074248A1 (en) 1999-07-08 2001-02-07 Arnold Hilgers Delivery system for biological material
US6699470B1 (en) * 1999-10-12 2004-03-02 Massachusetts Institute Of Technology Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
US6805879B2 (en) * 2000-06-23 2004-10-19 Biopharm Solutions Inc. Stable polymer aqueous/aqueous emulsion system and uses thereof
ATE381963T1 (de) * 2001-10-26 2008-01-15 Octoplus Technologies B V Verfahren zur herstellung von gereinigten partikeln
CA2497195C (en) * 2001-12-14 2014-07-08 The University Of Wyoming Methods and compositions for controlled release of drugs
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
EP1393718A1 (en) * 2002-08-29 2004-03-03 OctoPlus Sciences B.V. Colloidal drug carrier system
KR20060015469A (ko) * 2003-03-04 2006-02-17 더 테크놀로지 디벨로프먼트 컴퍼니 리미티드 경구용 인슐린 조성물 및 그 제조방법 및 사용방법
US8545830B2 (en) * 2003-03-24 2013-10-01 University Of Tennessee Research Foundation Multi-functional polymeric materials and their uses
TWI293317B (en) * 2003-12-31 2008-02-11 Ind Tech Res Inst Method for preparing polymer microspheres by aqueous phase-aqueous phase emulsion process
EP1576952A1 (en) * 2004-03-18 2005-09-21 OctoPlus Technologies B.V. Hydrogel microspheres with improved release profile
US7541048B2 (en) 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
JP5026956B2 (ja) * 2004-05-12 2012-09-19 サーモディクス,インコーポレイティド 医療用具のための天然生分解性多糖コーティング
WO2006013309A1 (en) * 2004-08-03 2006-02-09 Biocompatibles Uk Limited Drug delivery from embolic agents
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060141021A1 (en) * 2004-12-29 2006-06-29 Industrial Technology Research Polymeric microspheres and method for preparing the same
US8932633B2 (en) * 2005-08-29 2015-01-13 Biopharm Solutions Inc. Polysaccharide microparticles containing biological agents: their preparation and applications
JP5139301B2 (ja) * 2005-09-21 2013-02-06 サーモディクス,インコーポレイティド 生分解性天然多糖を含む被膜及び器具
JP5139302B2 (ja) * 2005-09-21 2013-02-06 サーモディクス,インコーポレイティド 天然生分解性多糖を用いたinsituにおける閉塞物の形成方法
US20070212703A1 (en) * 2005-09-27 2007-09-13 Stemmer Willem P Proteinaceous pharmaceuticals and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
WO2007059144A1 (en) * 2005-11-15 2007-05-24 Surmodics, Inc. Ultrasonic nozzles for applying two-component coatings
WO2007061896A1 (en) 2005-11-17 2007-05-31 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
US20070190127A1 (en) 2005-12-30 2007-08-16 Mingdong Zhou Extended release of neuregulin for improved cardiac function
US20080039931A1 (en) * 2006-04-25 2008-02-14 Surmodics, Inc. Hydrophilic shape memory insertable medical articles
US8968782B2 (en) * 2006-06-28 2015-03-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
WO2008002657A2 (en) * 2006-06-28 2008-01-03 Surmodics, Inc. Microparticles containing active agent dispersed in a polymer matrix as implant or as coating for medical devices
WO2008022258A2 (en) * 2006-08-16 2008-02-21 Surmodics, Inc. Methods and materials for increasing the adhesion of elution control matrices to substrates
US20080075753A1 (en) * 2006-09-25 2008-03-27 Chappa Ralph A Multi-layered coatings and methods for controlling elution of active agents
WO2008088593A2 (en) * 2006-09-27 2008-07-24 Surmodics, Inc. Additives and methods for enhancing active agent elution kinetics
EP2091623A4 (en) * 2006-11-17 2011-10-12 Gareth Michael Forde MATERIALS, METHODS AND SYSTEMS FOR PURIFICATION AND / OR SEPARATION OF MOLECULES
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
CN100471542C (zh) * 2006-12-15 2009-03-25 中国科学院长春应用化学研究所 一种分离超细微粒的工艺
US8771713B2 (en) * 2007-03-12 2014-07-08 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8741316B2 (en) * 2007-03-12 2014-06-03 Board Of Regents, The University Of Texas System Highly porous, recognitive polymer systems
WO2008112826A1 (en) * 2007-03-12 2008-09-18 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8821899B2 (en) * 2007-03-12 2014-09-02 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US20080243103A1 (en) * 2007-03-28 2008-10-02 Cook Urological Inc. Medical Device for Delivering a Bioactive and Method of Use Thereof
US8987230B2 (en) 2007-05-01 2015-03-24 National University Corporation Tokyo Medical And Dental University Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same
EP2025334A1 (en) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Sustained release drug delivery system for repeated administration
BRPI0815416A2 (pt) * 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
US20090214601A1 (en) * 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
WO2009091812A2 (en) * 2008-01-14 2009-07-23 Surmodics, Inc. Devices and methods for elution of nucleic acid delivery complexes
US7748452B2 (en) * 2008-02-19 2010-07-06 Schlumberger Technology Corporation Polymeric microspheres as degradable fluid loss additives in oilfield applications
MX2010010663A (es) 2008-03-28 2010-11-09 Surmodics Inc Dispositivos medicos insertables que tienen substratos elasticos asociados con microparticulas, y metodos de suministro de farmacos.
WO2009126830A2 (en) * 2008-04-09 2009-10-15 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
ES2604968T3 (es) 2008-04-28 2017-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
JP5763525B2 (ja) * 2008-05-07 2015-08-12 サーモディクス,インコーポレイティド 粒子からの核酸複合体の送達
EP2306929A1 (en) * 2008-07-14 2011-04-13 SurModics, Inc. Medical devices and methods for delivery of nucleic acids
WO2010091122A1 (en) * 2009-02-03 2010-08-12 Amunix, Inc. Extended recombinant polypeptides and compositions comprising same
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
US20110046721A1 (en) * 2009-08-10 2011-02-24 Surmodics, Inc. Biodegradable Metal-Polymer Composite Constructs For Implantable Medical Devices
BR112012004094A2 (pt) 2009-08-24 2016-03-08 Amunix Operating Inc composições de fator vii de coagulação e métodos para fazer e usar as mesmas
EP2493918A4 (en) 2009-10-30 2013-04-10 Ntf Therapeutics Inc IMPROVED NEURTURINE MOLECULES
US20110159098A1 (en) * 2009-12-30 2011-06-30 Surmodics, Inc. Stabilization and delivery of nucleic acid complexes
US8927000B2 (en) 2010-06-30 2015-01-06 Surmodics, Inc. Lipid coating for medical devices delivering bioactive agent
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2618924A1 (en) 2010-09-24 2013-07-31 Bend Research, Inc. High-temperature spray drying process and apparatus
US20120100187A1 (en) 2010-10-26 2012-04-26 Surmodics, Inc. Coatings and methods for controlled elution of hydrophilic active agents
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
LT2822577T (lt) 2012-02-15 2019-03-25 Bioverativ Therapeutics Inc. Rekombinantiniai faktoriaus viii baltymai
HRP20221531T1 (hr) 2012-02-15 2023-02-17 Bioverativ Therapeutics Inc. Pripravci faktora viii i postupci dobivanja i korištenja istih
MX351261B (es) 2012-06-01 2017-10-06 Surmodics Inc Aparato y método para recubrir catéteres con globo.
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
EP3033097B1 (en) 2013-08-14 2021-03-10 Bioverativ Therapeutics Inc. Factor viii-xten fusions and uses thereof
US10004753B2 (en) 2015-01-16 2018-06-26 The J. David Gladstone Institutes Methods for treating tauopathy
WO2017010518A1 (ja) 2015-07-13 2017-01-19 コスメディ製薬株式会社 薬物徐放性担体及びその製造方法
MX2018001497A (es) 2015-08-03 2018-05-15 Bioverativ Therapeutics Inc Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
EP4480544A3 (en) 2015-08-25 2025-03-26 Babita Agrawal Immunomodulatory compositions andmethods of use thereof
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
EP3205393A1 (en) 2016-02-12 2017-08-16 Basf Se Process for preparation of microcapsules
US10712240B2 (en) 2016-04-19 2020-07-14 Ariana Schanzer Contaminant monitor system and method
AU2017290593A1 (en) 2016-06-27 2019-01-03 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
WO2018102743A1 (en) 2016-12-02 2018-06-07 Bioverativ Therapeutics Inc. Methods of treating hemophilic arthropathy using chimeric clotting factors
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
RS66972B1 (sr) 2018-05-18 2025-07-31 Bioverativ Therapeutics Inc Metode lečenja hemofilije a
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
US11814391B2 (en) 2018-09-06 2023-11-14 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
WO2021127452A1 (en) 2019-12-19 2021-06-24 Georgia State University Research Foundation, Inc. Compounds for the treatment of bacterial infections and potentiation of antibiotics
US20250197403A1 (en) 2020-02-20 2025-06-19 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
CN116437913A (zh) 2020-09-23 2023-07-14 艾其林医药公司 用于治疗补体介导的病症的药物化合物
CN115109301A (zh) * 2021-03-18 2022-09-27 四川大学 一种中空开口二醋酸纤维素微球的制备方法
WO2025111713A1 (en) * 2023-12-01 2025-06-05 Tsai Scott S H Systems and methods of isolation of extracellular vesicles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
IT1268718B1 (it) * 1994-07-26 1997-03-06 Fidia Advanced Biopolymers Srl Sintesi di gel chimici da polisaccaridi polielettroliti tramite gamma irradiazione
US5827707A (en) * 1995-06-07 1998-10-27 Neocrin Company Method for manufacturing minimal volume capsules containing biological materials
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices

Similar Documents

Publication Publication Date Title
JP2000506265A5 (enExample)
JP2001504371A5 (enExample)
JP2000513333A5 (enExample)
JP2001503396A5 (enExample)
JP2000501018A5 (enExample)
JP2001502385A5 (enExample)
JP2001503295A5 (enExample)
JP2002514124A5 (enExample)
JP2000514708A5 (enExample)
JP2001504828A5 (enExample)
JP2001508362A5 (enExample)
JP2000513720A5 (enExample)
JP2000510865A5 (enExample)
JP2001504614A5 (enExample)
JP2001502349A5 (enExample)
JP2000507053A5 (enExample)
JP2001501447A5 (enExample)
JP2001500878A5 (enExample)
JP2001505855A5 (enExample)
JP2001511697A5 (enExample)
JP2001501714A5 (enExample)
JP2000510181A5 (enExample)
JP2000517102A5 (enExample)
JP2001505521A5 (enExample)
JP2000506908A5 (enExample)